abs380.txt	purpose		effective	treatment	of	patients	with	locally	advanced	pancreatic	canceris	a	significant	unmet	clinical	need		one	major	hurdle	that	exists	is	inadequatedrug	delivery	due	to	the	desmoplastic	stroma	and	poor	vascularization	that	ischaracteristic	of	pancreatic	cancer		the	local	iontophoretic	delivery	ofchemotherapies	provides	a	novel	way	of	improving	treatment		with	the	growingpractice	of	highly	toxic	combination	therapies	in	the	treatment	of	pancreaticcancer		the	use	of	iontophoresis	for	local	delivery	can	potentiate	theanti-cancer	effects	of	these	therapies	while	sparing	unwanted	toxicity		theobjective	of	this	study	was	to	investigate	the	impact	of	formulation	on	theelectro-transport	of	the	folfirinox	regimen	for	the	development	of	a	newtreatment	for	pancreatic	cancer	methods		three	formulations	of	the	folfirinox	regimen	(5-fluorouracil	leucovorin		irinotecan		and	oxaliplatin)	were	generated	at	a	fixed	ph	of	6	0	andwere	referred	to	as	formulation	a	(single	drug	solution	with	all	four	drugscombined)		formulation	b	(two	drug	solutions	with	two	drugs	per	solution)		andformulation	c	(four	individual	drug	solutions)		anodic	iontophoresis	of	the	threedifferent	formulations	was	evaluated	in	orthotopic	patient-derived	xenografts	ofpancreatic	cancer	results		iontophoretic	transport	of	the	folfirinox	drugs	was	characterizedaccording	to	organ	exposure	after	a	single	device	treatment	in	vivo		we	reportthat	the	co-iontophoresis	of	two	drug	solutions		leucovorin	+	oxaliplatin	and5-fluorouracil	+	irinotecan		resulted	in	the	highest	levels	of	cytotoxic	drugs	inthe	tumor	compared	to	drugs	delivered	individually	or	combined	into	one	solution	there	was	no	significant	difference	in	plasma		pancreas		kidney		and	liverexposure	to	the	cytotoxic	drugs	delivered	by	the	three	different	formulations		inaddition		we	found	that	reducing	the	duration	of	iontophoretic	treatment	from	10to	5	min	per	solution	resulted	in	a	significant	decrease	in	drug	concentrations	conclusions		underlying	the	difference	in	drug	transport	of	the	formulations	waselectrolyte	concentrations		which	includes	both	active	and	inactive	components	electrolyte	concentrations	can	hinder	or	improve	drug	electro-transport		overall	balancing	electrolyte	concentration	is	needed	for	optimal	electro-transport	
